ProHance
ProHance is a gadoteridol-based contrast media agent designed for contrast enhancement during magnetic resonance imaging (MRI). Each single-dose 10 mL vial contains 279.3 mg (0.5 mmol) of gadoteridol per mL in solution for intravenous use. This 1 x 5-vial pack supports consistent, reliable imaging workflows in clinical settings. DIN 02229056; listed as non-prescription in Canada and Quebec.
Description
ProHance is a gadoteridol-based contrast media agent designed for contrast enhancement during magnetic resonance imaging (MRI). Each single-dose 10 mL vial contains 279.3 mg (0.5 mmol) of gadoteridol per mL in solution for intravenous use. This 1 x 5-vial pack supports consistent, reliable imaging workflows in clinical settings. DIN 02229056; listed as non-prescription in Canada and Quebec.
